1,233 results on '"Carvalho Edgar"'
Search Results
2. Disseminated Leishmaniasis, a Severe Form of Leishmania braziliensis Infection
3. Evaluation of REE potential in Portuguese legacy mines
4. Assessment of immune and clinical response in patients with mucosal leishmaniasis treated with pentavalent antimony and pentoxifylline
5. Geochemical Behaviour of Rare Earth Elements Throughout an Acid Mine Drainage Passive Treatment System in the Lousal Mine Area, Portugal
6. Avaliação do poder sensibilizante da reação de Montenegro
7. Use of topical rSm29 in combination with intravenous meglumine antimoniate in the treatment of cutaneous leishmaniasis: A randomized controlled trial
8. Asymptomatic Leishmania chagasi Infection in Relatives and Neighbors of Patients with Visceral Leishmaniasis
9. Neurological manifestations in HTLV-1 patients with overactive bladder syndrome. A precursor of HAM/TSP?
10. Neurological disability in HTLV-1 infected individuals according to the initial clinical presentation: cohort study
11. Influence of HTLV-1 in the clinic, microbiologic and immunologic features of tuberculosis
12. Influence of HTLV-1 on the clinical, microbiologic and immunologic presentation of tuberculosis
13. Macrophages participate in host protection and the disease pathology associated with Leishmania braziliensis infection
14. Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-α production
15. CXCR1 and SLC11A1 polymorphisms affect susceptibility to cutaneous leishmaniasis in Brazil: a case-control and family-based study
16. The cause of urinary symptoms among Human T Lymphotropic Virus Type I (HLTV-I) infected patients: a cross sectional study
17. Resistance of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis to nitric oxide correlates with disease severity in Tegumentary Leishmaniasis
18. Differential effects of antigens from L. braziliensis isolates from disseminated and cutaneous leishmaniasis on in vitro cytokine production
19. Zinc/copper imbalance reflects immune dysfunction in human leishmaniasis: an ex vivo and in vitro study
20. Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers
21. Profile of T and B lymphocytes in individuals resistant to Schistosoma mansoni infection
22. Radiographic aspects in individuals infected by human T-lymphotropic virus type 1 (HTLV-1) with joint pain
23. Lesional senescent CD4+ T cells mediate bystander cytolysis and contribute to the skin pathology of human cutaneous leishmaniasis.
24. Anti-Leishmania IgG is a marker of disseminated leishmaniasis caused by Leishmania braziliensis
25. Association of miltefosine with granulocyte and macrophage colony-stimulating factor (GM-CSF) in the treatment of cutaneous leishmaniasis in the Amazon region: A randomized and controlled trial
26. Multi-omic Analyses of Plasma Cytokines, Lipidomics, and Transcriptomics Distinguish Treatment Outcomes in Cutaneous Leishmaniasis
27. The Role of Senescent CD8 + T Cells in the Pathogenesis of Disseminated Leishmaniasis.
28. In Situ versus Systemic Immune Response in the Pathogenesis of Cutaneous Leishmaniasis
29. Short communication: The miR-155a-5p is correlated with increased ROS and impaired apoptosis in macrophages infected by Leishmania braziliensis
30. ONABOTULINUMTOXIN TYPE A IMPROVES LOWER URINARY TRACT SYMPTOMS AND QUALITY OF LIFE IN PATIENTS WITH HUMAN T CELL LYMPHOTROPIC VIRUS TYPE 1 ASSOCIATED OVERACTIVE BLADDER
31. MicroRNAs regulating macrophages infected with Leishmania L. (V.) Braziliensis isolated from different clinical forms of American tegumentary leishmaniasis
32. Investigation of the pathways related to intrinsic miltefosine tolerance in Leishmania (Viannia) braziliensis clinical isolates reveals differences in drug uptake
33. Neurologic, clinical, and immunologic features in a cohort of HTLV-1 carriers with high proviral loads
34. Conference Highlights of the 16th International Conference on Human Retrovirology: HTLV and Related Retroviruses, 26–30 June 2013, Montreal, Canada
35. Forecasting temporal dynamics of cutaneous leishmaniasis in Northeast Brazil.
36. CCR5 promotes the migration of pathological CD8+ T cells to the leishmanial lesions.
37. Improved Treatment Outcome Following the Use of a Wound Dressings in Cutaneous Leishmaniasis Lesions.
38. Multiomic profiling of cutaneous leishmaniasis infections reveals microbiota-driven mechanisms underlying disease severity
39. CCR5 promotes the migration of CD8+ T cells to the leishmanial lesions
40. Regulatory T cells control Staphylococcus aureus and disease severity of cutaneous leishmaniasis
41. Leishmania braziliensis exosomes activate human macrophages to produce proinflammatory mediators
42. Prostaglandin e2 contributes to L. braziliensis survival and therapeutic failure in cutaneous leishmaniasis
43. Early Cutaneous Leishmaniasis Patients Infected With Leishmania braziliensis Express Increased Inflammatory Responses After Antimony Therapy
44. IL-1β Production by Intermediate Monocytes Is Associated with Immunopathology in Cutaneous Leishmaniasis
45. Onabotulinumtoxin type A improves lower urinary tract symptoms and quality of life in patients with human T cell lymphotropic virus type 1 associated overactive bladder
46. Impaired TNF, IL-1β, and IL-17 production and increased susceptibility to Mycobacterium tuberculosis infection in HTLV-1 infected individuals
47. Fluconazole in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis: A Randomized Controlled Trial
48. NKG2D promotes CD8 T cell-mediated cytotoxicity and is associated with treatment failure in human cutaneous leishmaniasis
49. Bioconcentration and translocation of rare earth elements in plants collected from three legacy mine sites in Portugal
50. Clinical Profile and Diagnosis of Recurrent Cutaneous Leishmaniasis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.